Year: 2019

Potential prostate cancer biomarkers

An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk.

All-in-one pill helps reduce blood pressure, cholesterol

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.

From left, Jennifer Pietenpol, PhD, VUMC Executive Vice President for Research, Vanderbilt Prize in Biomedical Science recipient Christine Seidman, MD, Vanderbilt Prize Scholar Megan Rasmussen and Lawrence Marnett, PhD, Dean of Basic Sciences, School of Medicine.

Genetics key to treating heart muscle disorders: Vanderbilt Prize lecturer

Advances in genetics are leading to new ways to treat cardiomyopathies — devastating heart muscle disorders that lead to heart failure.

Security software required for employees’ smartphones, tablets

To help prevent unauthorized data access, Vanderbilt University Medical Center is requiring employees who use their personal smartphones and digital tablets to conduct VUMC business to enroll in mobile device management by Feb. 1, 2020.

Jackson named to new VICC advanced practice role

Heather Jackson, MSN, RN, APRN, has been promoted to administrative director of Advanced Practice for Vanderbilt-Ingram Cancer Center.

Katie Cox Johnson, MD, at the opening of the Shade Tree Clinic.

Katie Cox Johnson, co-founder of Shade Tree Clinic, mourned

Katie Cox Johnson, co-founder of Vanderbilt University School of Medicine’s Shade Tree Clinic, died Sept. 11. She was 38.

1 19 20 21 22 23 69